Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects

Clinical trial NCT02568098 · COMPLETED

Trial details

NCT number: NCT02568098
Sponsor: University of Oxford
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Combination Pharmacokinetics Healthy

Start date: 2015-10-01
Primary completion: 2016-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.